Binghamton University scientists win seed funding for medical technologies

·2h ago
Share:PostShare

Two Binghamton University faculty members will receive seed funding through the State University of New York (SUNY) Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists.

M

Medical News

Original source

Read full story

Related Stories

Health8h ago

Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Envisagenics today announced a multi-year research collaboration and option agreement with Boehringer Ingelheim to validate selected tumor-specific targets for the development of first-in-class precision therapies for people living with solid tumors. Envisagenics has pioneered an artificial intelligence (AI)-powered approach that is transforming alternative RNA splicing into a new frontier for drug discovery.

GGlobe Newswire

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer